About Melio
Melio is a company based in Santa Clara (United States) founded in 2018 by Shelley Lawrence, Stephanie Fraley, and Mridu Sinha. It operates as a HealthTech. Melio has raised $4.25 million across 3 funding rounds from investors including IndieBio and LongeVC. Melio offers products and services including Melio Diagnostic Platform.
- Headquarter Santa Clara, United States
- Founders Shelley Lawrence, Stephanie Fraley, Mridu Sinha
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Melio, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.25 M (USD)
in 3 rounds
-
Latest Funding Round
$4 M (USD), Series A
Jun 28, 2024
-
Investors
IndieBio
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Melio
Melio offers a comprehensive portfolio of products and services, including Melio Diagnostic Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bloodborne pathogen testing is delivered rapidly and accurately.
Unlock access to complete
Unlock access to complete
Funding Insights of Melio
Melio has successfully raised a total of $4.25M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $4.0M
-
First Round
First Round
(22 Dec 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Series A - Melio | Valuation |
investors |
|
| May, 2023 | Amount | Seed - Melio | Valuation | LongeVC |
|
| Dec, 2022 | Amount | Seed - Melio | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Melio
Melio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include IndieBio and LongeVC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Founded Year | Domain | Location | |
|
LongeVC is focused on venture capital investments in biotech.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Melio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Melio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Melio Comparisons
Competitors of Melio
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Melio
When was Melio founded?
Melio was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Where is Melio located?
Melio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Who is the current CEO of Melio?
Mridu Sinha is the current CEO of Melio. They have also founded this company.
Is Melio a funded company?
Melio is a funded company, having raised a total of $4.25M across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Dec 22, 2022.
What does Melio do?
A culture-free, rapid, and comprehensive blood testing platform is developed by Melio to identify pathogens in hours instead of days. Focus is placed on critical applications such as newborn care in NICUs, where timely diagnosis is essential. Advanced systems engineering, microfluidics, and machine learning are integrated to ensure faster and precise treatments. The technology is designed to adapt and detect newly emerging pathogens, expanding its diagnostic database. Solutions are aimed at addressing global challenges like antibiotic resistance within the healthcare sector.
What products or services does Melio offer?
Melio offers Melio Diagnostic Platform.
Who are Melio's investors?
Melio has 2 investors. Key investors include IndieBio, and LongeVC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.